These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30929737)

  • 1. Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions.
    Aref-Eshghi E; Bend EG; Colaiacovo S; Caudle M; Chakrabarti R; Napier M; Brick L; Brady L; Carere DA; Levy MA; Kerkhof J; Stuart A; Saleh M; Beaudet AL; Li C; Kozenko M; Karp N; Prasad C; Siu VM; Tarnopolsky MA; Ainsworth PJ; Lin H; Rodenhiser DI; Krantz ID; Deardorff MA; Schwartz CE; Sadikovic B
    Am J Hum Genet; 2019 Apr; 104(4):685-700. PubMed ID: 30929737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders.
    Poole RL; Docherty LE; Al Sayegh A; Caliebe A; Turner C; Baple E; Wakeling E; Harrison L; Lehmann A; Temple IK; Mackay DJ;
    Am J Med Genet A; 2013 Sep; 161A(9):2174-82. PubMed ID: 23913548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methylation in the Diagnosis of Monogenic Diseases.
    Cerrato F; Sparago A; Ariani F; Brugnoletti F; Calzari L; Coppedè F; De Luca A; Gervasini C; Giardina E; Gurrieri F; Lo Nigro C; Merla G; Miozzo M; Russo S; Sangiorgi E; Sirchia SM; Squeo GM; Tabano S; Tabolacci E; Torrente I; Genuardi M; Neri G; Riccio A
    Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32224912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Validation of a Genome-Wide DNA Methylation Assay for Molecular Diagnosis of Imprinting Disorders.
    Aref-Eshghi E; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Siu V; Rodenhiser D; Schwartz C; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):848-856. PubMed ID: 28807811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.
    Aref-Eshghi E; Rodenhiser DI; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Hood RL; Bulman DE; Kernohan KD; ; Boycott KM; Campeau PM; Schwartz C; Sadikovic B
    Am J Hum Genet; 2018 Jan; 102(1):156-174. PubMed ID: 29304373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.
    Chater-Diehl E; Ejaz R; Cytrynbaum C; Siu MT; Turinsky A; Choufani S; Goodman SJ; Abdul-Rahman O; Bedford M; Dorrani N; Engleman K; Flores-Daboub J; Genevieve D; Mendoza-Londono R; Meschino W; Perrin L; Safina N; Townshend S; Scherer SW; Anagnostou E; Piton A; Deardorff M; Brudno M; Chitayat D; Weksberg R
    BMC Med Genomics; 2019 Jul; 12(1):105. PubMed ID: 31288860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of multilocus methylation-specific single nucleotide primer extension (MS-SNuPE) technology in diagnostic testing for human imprinted loci.
    Begemann M; Leisten I; Soellner L; Zerres K; Eggermann T; Spengler S
    Epigenetics; 2012 May; 7(5):473-81. PubMed ID: 22419125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in
    Schenkel LC; Aref-Eshghi E; Skinner C; Ainsworth P; Lin H; Paré G; Rodenhiser DI; Schwartz C; Sadikovic B
    Clin Epigenetics; 2018; 10():21. PubMed ID: 29456765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders.
    Haghshenas S; Bhai P; Aref-Eshghi E; Sadikovic B
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome.
    Schenkel LC; Aref-Eshghi E; Rooney K; Kerkhof J; Levy MA; McConkey H; Rogers RC; Phelan K; Sarasua SM; Jain L; Pauly R; Boccuto L; DuPont B; Cappuccio G; Brunetti-Pierri N; Schwartz CE; Sadikovic B
    Clin Epigenetics; 2021 Jan; 13(1):2. PubMed ID: 33407854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFopathies' DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin-Siris and Nicolaides-Baraitser syndromes.
    Aref-Eshghi E; Bend EG; Hood RL; Schenkel LC; Carere DA; Chakrabarti R; Nagamani SCS; Cheung SW; Campeau PM; Prasad C; Siu VM; Brady L; Tarnopolsky MA; Callen DJ; Innes AM; White SM; Meschino WS; Shuen AY; Paré G; Bulman DE; Ainsworth PJ; Lin H; Rodenhiser DI; Hennekam RC; Boycott KM; Schwartz CE; Sadikovic B
    Nat Commun; 2018 Nov; 9(1):4885. PubMed ID: 30459321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted long-read sequencing identifies missing disease-causing variation.
    Miller DE; Sulovari A; Wang T; Loucks H; Hoekzema K; Munson KM; Lewis AP; Fuerte EPA; Paschal CR; Walsh T; Thies J; Bennett JT; Glass I; Dipple KM; Patterson K; Bonkowski ES; Nelson Z; Squire A; Sikes M; Beckman E; Bennett RL; Earl D; Lee W; Allikmets R; Perlman SJ; Chow P; Hing AV; Wenger TL; Adam MP; Sun A; Lam C; Chang I; Zou X; Austin SL; Huggins E; Safi A; Iyengar AK; Reddy TE; Majoros WH; Allen AS; Crawford GE; Kishnani PS; ; King MC; Cherry T; Chong JX; Bamshad MJ; Nickerson DA; Mefford HC; Doherty D; Eichler EE
    Am J Hum Genet; 2021 Aug; 108(8):1436-1449. PubMed ID: 34216551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.
    Aref-Eshghi E; Kerkhof J; Pedro VP; ; Barat-Houari M; Ruiz-Pallares N; Andrau JC; Lacombe D; Van-Gils J; Fergelot P; Dubourg C; Cormier-Daire V; Rondeau S; Lecoquierre F; Saugier-Veber P; Nicolas G; Lesca G; Chatron N; Sanlaville D; Vitobello A; Faivre L; Thauvin-Robinet C; Laumonnier F; Raynaud M; Alders M; Mannens M; Henneman P; Hennekam RC; Velasco G; Francastel C; Ulveling D; Ciolfi A; Pizzi S; Tartaglia M; Heide S; Héron D; Mignot C; Keren B; Whalen S; Afenjar A; Bienvenu T; Campeau PM; Rousseau J; Levy MA; Brick L; Kozenko M; Balci TB; Siu VM; Stuart A; Kadour M; Masters J; Takano K; Kleefstra T; de Leeuw N; Field M; Shaw M; Gecz J; Ainsworth PJ; Lin H; Rodenhiser DI; Friez MJ; Tedder M; Lee JA; DuPont BR; Stevenson RE; Skinner SA; Schwartz CE; Genevieve D; Sadikovic B
    Am J Hum Genet; 2020 Mar; 106(3):356-370. PubMed ID: 32109418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of rare de novo epigenetic variations in congenital disorders.
    Barbosa M; Joshi RS; Garg P; Martin-Trujillo A; Patel N; Jadhav B; Watson CT; Gibson W; Chetnik K; Tessereau C; Mei H; De Rubeis S; Reichert J; Lopes F; Vissers LELM; Kleefstra T; Grice DE; Edelmann L; Soares G; Maciel P; Brunner HG; Buxbaum JD; Gelb BD; Sharp AJ
    Nat Commun; 2018 May; 9(1):2064. PubMed ID: 29802345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation and RNA analyses enable reclassification of two variants of uncertain significance in a patient with clinical Kabuki syndrome.
    Aref-Eshghi E; Bourque DK; Kerkhof J; Carere DA; Ainsworth P; Sadikovic B; Armour CM; Lin H
    Hum Mutat; 2019 Oct; 40(10):1684-1689. PubMed ID: 31268616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders.
    Sadikovic B; Levy MA; Kerkhof J; Aref-Eshghi E; Schenkel L; Stuart A; McConkey H; Henneman P; Venema A; Schwartz CE; Stevenson RE; Skinner SA; DuPont BR; Fletcher RS; Balci TB; Siu VM; Granadillo JL; Masters J; Kadour M; Friez MJ; van Haelst MM; Mannens MMAM; Louie RJ; Lee JA; Tedder ML; Alders M
    Genet Med; 2021 Jun; 23(6):1065-1074. PubMed ID: 33547396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases.
    Kerkhof J; Rastin C; Levy MA; Relator R; McConkey H; Demain L; Dominguez-Garrido E; Kaat LD; Houge SD; DuPont BR; Fee T; Fletcher RS; Gokhale D; Haukanes BI; Henneman P; Hilton S; Hilton BA; Jenkinson S; Lee JA; Louie RJ; Motazacker MM; Rzasa J; Stevenson RE; Plomp A; van der Laan L; van der Smagt J; Walden KK; Banka S; Mannens M; Skinner SA; Friez MJ; Campbell C; Tedder ML; Alders M; Sadikovic B
    Genet Med; 2024 May; 26(5):101075. PubMed ID: 38251460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders.
    Sadikovic B; Levy MA; Aref-Eshghi E
    Hum Mol Genet; 2020 Sep; 29(R1):R27-R32. PubMed ID: 32644126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants.
    Middelkamp S; Vlaar JM; Giltay J; Korzelius J; Besselink N; Boymans S; Janssen R; de la Fonteijne L; van Binsbergen E; van Roosmalen MJ; Hochstenbach R; Giachino D; Talkowski ME; Kloosterman WP; Cuppen E
    Genome Med; 2019 Dec; 11(1):79. PubMed ID: 31801603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epigenetics, genomic imprinting and developmental disorders].
    Le Bouc Y; Rossignol S; Azzi S; Brioude F; Cabrol S; Gicquel C; Netchine I
    Bull Acad Natl Med; 2010 Feb; 194(2):287-97; discussion 297-300. PubMed ID: 21166119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.